NVAX – novavax, inc. (US:NASDAQ)

News

Novavax (NASDAQ:NVAX) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $19.00 price target on the stock.
Novavax Announces Entering into a License Agreement with Pfizer
2 Growth Stocks with Explosive Upside and 1 That Underwhelm [Yahoo! Finance]
JPM26: Matrix-M Technology is central to Novavax's strategy [Yahoo! Finance]
85 years of bold discovery: Texas Biomed marks milestone anniversary [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com